Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac)

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac) Publisher

Hajivalizadeh S¹ ; Akhondzadeh S²

Show Affiliations

1. Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
2. Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Iranian Medical Council Published:2024

[No abstract available]

Style	Citing Format
MLA	Hajivalizadeh S, Akhondzadeh S. "Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac)." Journal of Iranian Medical Council, vol. 7, no. 2, 2024, pp. 189-191.
APA	Hajivalizadeh S, Akhondzadeh S (2024). Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac). Journal of Iranian Medical Council, 7(2), 189-191.
Chicago	Hajivalizadeh S, Akhondzadeh S. "Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac)." Journal of Iranian Medical Council 7, no. 2 (2024): 189-191.
Harvard	Hajivalizadeh S, Akhondzadeh S (2024) 'Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac)', Journal of Iranian Medical Council, 7(2), pp. 189-191.
Vancouver	Hajivalizadeh S, Akhondzadeh S. Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac). Journal of Iranian Medical Council. 2024;7(2):189-191.
BibTex	@article{ author = {Hajivalizadeh S and Akhondzadeh S}, title = {Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac)}, journal = {Journal of Iranian Medical Council}, volume = {7}, number = {2}, pages = {189-191}, year = {2024} }
RIS	TY - JOUR AU - Hajivalizadeh S AU - Akhondzadeh S TI - Immunotherapy Perspectives for Pancreatic Ductal Adenocarcinoma (Pdac) JO - Journal of Iranian Medical Council VL - 7 IS - 2 SP - 189 EP - 191 PY - 2024 ER -